insights_auto
Why is PGEN up 4.02%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
$8.54
arrow_upward
+4.02%(+0.33) 1D
$8.57
arrow_upward
+0.39% (+0.034)bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$8.30
High
$8.55
Low
$8.18
Mkt. cap
3.06B
Avg. vol.
4.78M
Volume
6.36M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
Open
$8.30
High
$8.55
Low
$8.18
Mkt. cap
3.06B
Avg. vol.
4.78M
Volume
6.36M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com